Catalog Advanced Search
-
Contains 24 Component(s)
Listing of upcoming sleep-related meetings
A listing of endorsed meetings for sleep professionals. Most meetings are hosted by various sleep societies.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 25 Component(s)
Full library of recordings from the Asian Society of Sleep Medicine 2025 meeting in Singapore.
Founded in 2015, the Asian Society of Sleep Medicine promotes all aspects of sleep medicine and research in Asia. The ASSM regularly holds scientific meetings to encourage international exchange and knowledge transfer in sleep medicine, advancing sleep health for all Asian populations.
Organizing Committee
- Yuichi Inoue (Japan) – Chair
- Ahmed S. BaHammam (Saudi Arabia)
- Fang Han (China)
- Hiroshi Kadotani (Japan)
- KiYoung Jung (Korea)
- Leow Leong-Chai (Singapore)
- Michael Chee (Singapore)
- Naricha Chirakalwasan (Thailand)
- SC Hong (Korea)
- Stijn Massar (Singapore)
- Toh Song Tar (Singapore)
- Yukiyoshi Sumi (Japan)
- Yun Kwok Wing (Hong Kong)
- Yuta Takano (Japan)
Program Committee
- Ahmed S. BaHammam (Saudi Arabia)
- Duong-Quy Sy (Vietnam)
- Fang Han (China)
- Hiroshi Kadotani (Japan)
- JC Suri (India)
- Leow Leong-Chai (Singapore)
- Michael Chee (Singapore)
- Mohamed A. Al-Abri (Oman)
- Naricha Chirakalwasan (Thailand)
- Ning-Hung Chen (Taiwan)
- Seockhoon Chung (Korea)
- Seung Bong Hong (Korea)
- Seung-Chul Hong (Korea)
- Stijn Massar (Singapore)
- Tayard Desudchit (Thailand)
- Toh Song Tar (Singapore)
- Yuichi Inoue (Japan)
- Yuta Takano (Japan)
- Yun-Kwok Wing (Hong Kong)
- Zhi-Li Huang (China)
Meeting Overview
Two scientific tracks all day on Saturday and Sunday (September 6 and 7)
3 keynote lectures
Symposia, oral presentations, and case studies
Dedicated poster hall session on Sunday evening (September 7)
Social reception on Saturday evening (September 6)
Dedicated exhibition room on Saturday and Sunday-
Register
- Non-member - $160
- Regular Member - $160
- Student Member - $160
- Technician Member - $160
- More Information
-
Contains 2 Component(s)
This symposium was presented in person at World Sleep 2025 in Singapore.
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the course by navigating to the timestamp indicated below.
0:00:00
Introduction: The phenotypic clinical diversity of RLS
Diego Garcia-Borreguero (Spain)
0:32:20
Pediatric RLS phenotypes: Early onset and unique challenges
Gulcin Benbir Senel (Turkey)
1:00:05
Adult RLS phenotypes: Clinical variability in adulthood
Claudia Trenkwalder (Germany)
Genetic insights into RLS: Shared variants and comorbidities
Arthur Walters (United States)Summary
Restless Legs Syndrome (RLS) encompasses a diverse spectrum of clinical presentations, each with unique implications for diagnosis, management, and research. This symposium will explore the proposed distinct phenotypes of RLS, highlighting shared genetic underpinnings, clinical manifestations, and treatment challenges. Experts in the field will discuss the current understanding of these phenotypes and identify areas for future research and therapeutic advancements.
The first presentation will provide a comprehensive overview of these diverse clinical profiles, setting the stage for deeper exploration in subsequent talks. It will highlight the variability in symptom frequency and severity, drawing on findings from recent clinical studies and patient-reported outcomes. Attendees will gain a foundational understanding of the phenotypic spectrum of RLS symptoms, equipping them with the knowledge to contextualize more specific discussions on subtypes, comorbidities, and management strategies. Also, the rationale for selection of different therapies across phenotypes will be outlined and discussed.
The second presentation will provide a detailed review of pediatric RLS phenotypes, drawing from contemporary literature to explore how RLS presents differently in children compared to adults. The talk will highlight the often subtle and atypical symptoms in children, including behavioral manifestations such as restlessness, inattention, or sleep resistance, which can mimic conditions like ADHD. The role of iron deficiency, developmental changes, and familial predisposition as key factors influencing pediatric RLS will be presented . Additionally, the overlap between RLS and other pediatric sleep disorders will be discussed, such as periodic limb movement disorder (PLMD), and the importance of early diagnosis to prevent long-term consequences on sleep and neurocognitive development.
The third speaker will provide a comprehensive review of adult RLS phenotypes, drawing from the latest literature to explore the variability in clinical presentations, relationship with insomnia, cardiovascular disorders, and mood disorders, among other comorbidities that contribute to symptom severity and progression. This talk with present the findings from adult RLS literature and discuss the implications for personalized diagnostic and therapeutic approaches in clinical practice.
Finally, the symposium will explore the genetic underpinnings of these associations, presenting findings from two innovative studies leveraging Genome-Wide Association Studies (GWAS) and Phenome-Wide Association Studies (PheWAS). The first study identifies 365 genetic variants associated with RLS, including significant overlap with hypertension, insomnia, ADHD, and circadian rhythm disturbances, providing insights into shared genetic susceptibilities. The second study extends these findings by replicating RLS associations for 84 variants and identifying additional links with conditions like thyroid disease, rheumatoid arthritis, and diabetes. Together, these studies demonstrate the utility of GWAS and PheWAS approaches in unraveling the genetic architecture of RLS and its frequent co-occurrence with other medical conditions. Attendees will gain a deeper understanding of how shared genetic pathways may inform future diagnostic and therapeutic strategies for RLS and its comorbidities.Learning Objectives:
Upon completion of this CME activity, participants will be able to:
• Gain an understanding of the phenotypic spectrum of RLS symptoms, equipping them with the knowledge to contextualize more specific discussions on subtypes, comorbidities, and management
• Recognize that RLS manifests with unique presentations in pediatric populations. It will highlight the often subtle and atypical symptoms in children, including behavioral manifestations such as restlessness, inattention, or sleep resistance, which can mimic conditions like ADHD. It will emphasize the role of iron deficiency, developmental changes, and familial predisposition
• Demonstrate that RLS exhibits diverse phenotypes in adulthood, as influenced by age, gender, and environmental factors. The talk will provide a comprehensive review of RLS phenotypes, drawing from the latest literature to explore the variability in clinical presentations, relationship with insomnia, cardiovascular and mood disorders, and contribute to symptom severity and progression
• Describe findings from two studies on GWAS and PheWAS. While the first study identified 365 genetic variants associated with RLS, including significant overlap with hypertension, insomnia, ADHD, and circadian disturbances, the second replicated associations for 84 variants and identified additional links with thyroid disease, rheumatoid arthritis, and diabetes-
Register
- Non-member - $100
- Regular Member - $100
- Student Member - $100
- Technician Member - $100
- More Information
-
Register
-
Contains 165 Product(s)
Access the full library of scientific program recordings from World Sleep 2025 in Singapore. (Courses Sold Separately)
After purchasing the bundle, navigate to the Content tab and activate sessions of interest to add them to your dashboard.
This bundle gives you access to the following sessions:
Keynotes
- K-01: Thomas Penzel: Innovations in sleep technology: Advancing diagnosis and treatment of sleep disorders
- K-02: Russell Foster: Light, circadian rhythms and sleep: Fundamental mechanisms to new therapeutics
- K-03: Tiina Paunio: Sleep and development: Exploring the impact of sleep on mental health in children
- K-04: Hiroki R. Ueda: Towards human systems biology of sleep/wake cycles: The role of calcium and phosphorylation in sleep
- K-05: Lauren Hale: Sleep health as a human right
- K-06: Bei Bei: Behavioral sleep interventions in women across the lifespan
- K-07: Mary Ip: Cardiometabolic consequences of obstructive sleep apnea: Are we making progress?
- K-08: Célyne Bastien: Sleep misperception: A waking perspective
- K-09: Takafumi Kato: Advances in dental sleep medicine: Understanding the pathophysiology of sleep bruxism and co-existing sleep disorders
- K-10: Ronald Postuma: REM sleep behavior disorder: Gateway to early diagnosis and therapy in synucleinopathies
- K-11: Björn Rasch: Sleep and memory: Current state of research and future needs
- K-12: Joshua J. Gooley: The hard facts supporting later learning start times
Symposia
- S-01: Pharmacotherapy of obstructive sleep apnea in 2025
- S-02: The Global Adolescent Sleep Project (GASP): A Summary of the Findings, Research Gaps and Future Directions
- S-03: Challenges of using cognitive behavioral treatment for insomnia in specific patient groups and settings
- S-04: WSS Task Force recommendations for use of consumer health trackers for sleep tracking
- S-05: OSA, neurodegeneration and neurocognitive decline: New insights and future directions
- S-06: Sleep health and aging: A decade research and its global implications
- S-07: Hypersomnolence in focus: Orexin as the key to treating comorbidities and secondary diseases?
- S-08: Decoding neurological sleep disorders: Genetic and omics approaches to advance clinical practice
- S-09: The medical and dental aspects of Asian and Caucasian populations in cardiosleep outcomes with oral appliance therapy on sleep-disordered breathing, blood pressure control, and maladaptive myocardial remodelling
- S-10: Mechanisms underlying REM sleep memory modification
- S-11: Prefrontal cortical orchestration of sleep: The missing link between sleep disruption and psychiatric disease?
- S-12: Narcolepsy: Examining the science, impact, and current unmet needs
- S-13: World Health Organization report on road safety: Pathway to global professional driver work hours regulations
- S-14: 45 years on from CPAP: Therapeutic options for pediatric OSA
- S-15: Sleep loss increases intrusive memories: But, how?
- S-16: Sleep and health problems among shift workers across the world: Novel findings, challenges, and future perspectives
- S-17: Discussion group: Leading the charge: Sleep medicine’s role in a healthier planet
- S-18: iRBD biomarkers through the lens of young scientists: What do we have and what do we need?
- S-19: Associations of accelerometry-derived sleep variables with age-related disease outcomes and variations across sociodemographic groups and wearing time: Findings from the CHARGE Accelerometry Working Group
- S-20: Exploring the intersections of sleep bruxism, orofacial pain, insomnia, and obstructive sleep apnea
- S-21: Current evidence on cardiometabolic diseases and sleep disorders; Asian Perspectives
- S-22: Patterns of plates and pillows: Exploring the bidirectional interplay between sleep and circadian rhythms, and eating behavior and metabolic outcomes
- S-23: Harnessing sensors and big data to decipher the link between sleep health and cardiovascular risk: Innovations and applications
- S-24: Novel approaches to address sleep problems in young children: Evidence from 5 randomized controlled trials
- S-25: Open data and open science in sleep medicine and sleep research
- S-26: Advancing biomarkers in isolated REM sleep behavior disorder: Pathways to clinical implementation
- S-27: Symptom subtypes of obstructive sleep apnea: Past, present, and future
- S-28: Global insights and emerging perspectives on sleep (ir)regularity
- S-29: ISSS symposium: Neurostimulation in the treatment obstructive sleep apnea: Current understanding, challenges and the future
- S-30: New insights and opportunities into sleep and pregnancy health with wearable big data and digital health interventions
- S-31: Sleep and digital media myth-busting: What should the recommended guidelines be for children, adolescents and young adults?
- S-32: Sleep, sleep disorders and neurodegenerative diseases: Novel insights on mechanisms and interventions
S-33: Global sleep health in turbulent times: Effects of political instability on funding, advocacy and health services(Session Not Available)- S-34: Discussion group: Artificial intelligence in sleep medicine: The good, the bad, the ugly
- S-35: Sleep-Immune interactions and the role of sleep in Long COVID
- S-36: Discussion group: Cannabis for the treatment of sleep disorders: What's the POT-ential?
- S-37: Social and neuropsychological outcomes in central disorders of hypersomnolence
- S-38: New circuits underlying REM sleep regulation and homoeostasis
- S-39: Sleep well, feel well: Enhancing mental health across the lifespan through sleep interventions
- S-40: Best of SLEEP MEDICINE – Journal Highlights 2025
- S-41: To wake up or continue sleep: Arousal dynamics and sleep stability in health and disease
- S-42: Revolutionizing personalized medicine in OSA: Exploring new treatment modalities
- S-43: Insomnia Sub-typing: Pathophysiology, phenotypes and differential treatment response
- S-44: Sleep and cardiometabolic health: Pathophysiology, and novel preventive and therapeutic strategies
- S-45: The role of autovideosomnography in research: How AI and big data are transforming pediatric sleep and development research
- S-46: How sleep shapes memory dynamics from the lens of reactivation: New insights and future directions
- S-47: Beyond the lab: Measuring sleep and circadian rhythms in naturalistic settings
- S-48: Discussion group: Optimizing opioid therapy for restless legs syndrome /Willis-Ekbom disease: Insights from basic science to clinical practice
- S-49: New insights into the waking, sleeping and dreaming brain
- S-50: Bridging sleep research and practice: Leveraging implementation science to improve sleep equity around the globe
S-51: The latest advances in understanding maternal sleep as a modifiable contributor to safer outcomes for mother and baby(Session Not Available)- S-52: Sleep Challenge 2025 Exhibition: Predicting all-cause mortality using physiological signals from the PSG
- S-53: Illuminating the minds: Impact of light exposure on circadian rhythms and health
- S-54: Advancing the definition and management of childhood obstructive sleep apnea (OSA)
- S-55: Advancing ambulatory sleep monitoring and diagnostics through innovative sensor technologies
- S-56: Obesity and the effects of GLP-1 agonists on OSA
- S-57: Narcolepsy meets immunology: Recent global discoveries in its pathophysiology
- S-58: Discussion group: Religious and spiritual determinants of sleep health
- S-59: Understanding the therapeutic opportunities of iron treatment in RLS
- S-60: Collaborative strategies for optimizing pediatric sleep health
- S-61: Sleep and the microbiome
S-62: Rethinking mask selection for CPAP and non-invasive ventilation: Facts and perspectives(Session Not Available)- S-63: Global efforts to combat drowsy driving: Opportunities and challenges to save more lives
- S-64: Discussion Group: Managing patients with obstructive sleep apnea and obesity with GLP-1 receptor agonists
- S-65: Night shift work and health risks: Internal desynchrony and underlying mechanisms
- S-66: Phenotypic spectrum of restless legs syndrome: Clinical insights and research perspectives
- S-67: Toward understanding dream interpretation: Mechanisms and functions of REM sleep
- S-68: Adolescent sleep and mental health: From challenges to solutions
- S-69: Discussion group: Global perspectives on sleep health advocacy: Insights and experiences across five continents
- S-70: Ecology of sleep strategies: Placing sleep function in a broader context
- S-71: Cracking the code: Deep signal analysis in sleep-disordered breathing
- S-72: Advances in proteomics, glycomics, and transcriptomics of sleep disorders
S-73: Discussion group: "Simple" snoring: Not simple, not hopeless(Session Not Available)- S-74: Harmonizing pediatric sleep: Navigating the complexities and diversities in managing sleep-related breathing disorders across borders
- S-75: Can OSA in adults be prevented by interventions in children?
- S-76: Practical telemonitoring implementation to improve outcomes in home mechanical ventilation globally, across diverse clinical settings and regions
- S-77: Restless legs syndrome and cardio-cerebro-vascular disease: Clinical associations and implications
- S-78: The role of glia in sleep regulation and sleep homeostasis: Implications for cognitive function and mental health
- S-79: Sleep as a window to health: Artificial intelligence-enabled digital sleep biomarkers for disease prediction
- S-80: Cognitive symptoms in narcolepsy and idiopathic hypersomnia: Neurobiology, functional impact, and clinical research
- S-81: Guiding light for metabolic health: Lessons from bench to field studies for therapeutic insights
- S-82: Tales from the edge: What can we learn about sleep from non-WEIRD (Western, Educated, Industrialized, Rich, and Democratic) sleep research?
- S-83: RBD 1985-2025: Novel perspectives
- S-84: Napping and its associations with health and cognition across the life span
- S-85: Consumer sleep technology: Usefulness and reliability for patients and practitioners
- S-86: AI approaches in pediatric sleep: Unraveling developmental sleep issues
- S-87: Innovative approaches to sleep Disorders and craniofacial health: Bridging research and clinical practice
- S-88: Gender disparities in obesity hypoventilation syndrome: From diagnosis and treatment to outcomes
- S-89: Novel developments in psychotherapy for insomnia
- S-90: Restless legs syndrome: Exploring genetic diversity, racial differences, and phenotypes
- S-91: The impact of sleep on frailty, sarcopenia, and falls: Investigating novel risk factors in aging populations
- S-92: The impact of war on sleep: Uncovering the mechanisms that link trauma exposure and sleep quality across different cohorts and age groups
- S-93: Unveiling and addressing sleep health disparities in indigenous peoples around the world
- S-94: The link between heart rate variability, autonomic alterations, and sleep disorders across lifespan and pathologies
- S-95: No strings attached: Harnessing novel contactless technology for sleep health and beyond
- S-96: Circadian rhythm sleep-wake disorders: Relevance to behavior and comorbidity
- S-97: Obstructive sleep, apnea: Studies by early-stage investigators
- S-98: Beyond the classical pentad: Narcolepsy from a multimodal perspective
- S-99: Promoting infant sleep in different cultures: Lessons from developing, adapting and evaluating innovative sleep interventions for infants in various cultures
- S-100: The rhythm of rest: Exploring the cognitive and psychological benefits and drawbacks associated with intraindividual variability in sleep
- S-101: ISSS symposium: The role of anatomic surgery in adult sleep apnea patients failing conventional treatments: Latest evidence and guidelines
- S-102: Digital advancements in oral appliance therapy for obstructive sleep apnea
- S-103: Cardiovascular implications of sleep disruption in women: Emerging evidence and clinical implications
- S-104: Shaping the future of sleep medicine: Evidence, innovations, and insights from Sleep Revolution
- S-105: Waking up the workforce: Exploring the impact of sleep on workplace performance, decision-making, and outcomes
- S-106: World clock: Turning back time on diagnostic delays in NT1
- S-107: Beyond scoring: Transforming sleep medicine with AI
- S-108: Sleep, sleep apnea, and heart rhythm: All you can learn
- S-109: Examining sleep contributions to pathways from stress to affective psychopathology in children and youth
- S-110: Chrononutrition to optimize health
- S-111: Translation of endo-phenotyping of adult obstructive sleep apnea to the clinic
- S-112: Targeting sleep disturbances in mental disorders: Does it make the difference?
- S-113: The mind throughout the sleep-wake cycle: The importance of cognitive phenomenology in sleep clinics
- S-114: New insights on the control of breathing during sleep and innovative genetic approaches for obstructive sleep apneas
- S-115: Sleep in athletes and the application to occupational settings
- S-116: The role of sleep and circadian factors for motivation and behavior
- S-117: Artificial intelligence approaches to physiologic signals in sleep medicine
- S-118: The molecular link between sleep and neurodevelopment
- S-119: Empowering women's sleep health through artificial intelligence
- S-120: Sleep and long COVID: From epidemiology to future prevention on behalf of Second International COVID-19 Sleep Study (ICOSS-II) group
- S-121: Novel sleep intervention trials for enhancing brain health across the lifespan
- S-122: Children's sleep in context: The role of social, economic, and educational policy and practice in early sleep development
- S-123: The waking nightmare: Unraveling the evidence behind the intertwined pathways between sleep and cancer
Oral Abstract Sessions
- O-01: Advancing surgical and neurostimulation therapies for obstructive sleep apnea
- O-02: Orexin-based therapies and pharmacological advances in narcolepsy
- O-03: Sleep health trajectories in childhood and adolescence
- O-04: Basic Science: Sleep deprivation and sleep disorder
- O-05: Optimizing therapeutic strategies and outcomes in obstructive sleep apnea management
- O-06: Innovations in the diagnosis and management of RLS
O-07: Dental and surgical sleep medicine interactions(Session Not Available)- O-08: Light and sleep health
- O-09: Targeting the orexin pathway: Emerging pharmacotherapies for narcolepsy type 1
- O-10: Novel approaches to treating insomnia
- O-11: Sleep in childhood and adolescence
- O-12: Basic research: Animal models of sleep and sleep disorder
- O-13: New sensing or signal analysis methods in sleep
- O-14: Sleep and circadian regulation of cognition and memory
- O-15: Psychiatric disorders affecting wake / sleep
- O-16: Sleep and aging brains: Patterns, risks, and predictive insights
- O-17: Biomarkers, phenotyping, and cognitive aspects in narcolepsy and hypersomnolence
- O-18: Tracking sleep: Tools, trends, and tailored interventions
- O-19: New Investigator Award
O-20: Sleep and sleep deprivation neurophysiology(Session Not Available)- O-21: Phenotyping and variability in obstructive sleep apnea: Implications for cardiovascular risk and personalized management
- O-22: The science of sleep health: Biomarkers, behavior, and big data
- O-23: Neurophysiological signatures and technological innovations in sleep apnea detection and impact assessment
O-24: Treatment and risk factor modifications in circadian rhythm disorders(Session Not Available)- O-25: Biomarkers and neuroimaging in prodromal RBD and synucleinopathies
- O-26: Infant and preschool sleep: Patterns and problems
- O-27: Rethinking daytime sleepiness: Multimodal approaches to identification and management
- O-28: Chronobiology and neurophysiology in early neurodegeneration
- O-29: Pediatric sleep-disordered breathing: Diagnostic innovation, biological mechanisms, and therapeutic strategies in complex and vulnerable populations
- O-30: Sleep and public health: Stress, climate, and community
- O-31: Management of insomnia with digital CBT-I
- O-32: Pathophysiological and diagnostic advances in RBD and NREM parasomnias
- O-33: Multisystem pathophysiology and biomarker discovery in sleep apnea
- O-34: Mechanisms and modulation of sleep-related cognitive dysfunction
- O-35: Novel sleep technology approaches with clinical applications
- O-36: Neurophysiology of sleep and cognitive aging
- O-37: Symptomatology, phenotypes, and pathophysiology of insomnia
-
Register
- Non-member - $900
- Regular Member - $450
- Student Member - $450
- Technician Member - $450
- More Information
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
Managing insomnia disorder in patients with neurological and psychiatric comorbidities
The impact of insomnia disorder for patients
David Neubauer
United StatesNew clinical data on daridorexant for managing insomnia disorder
Atul Khullar
CanadaClinical experience managing insomnia disorder in patients with psychiatric comorbidities
Laura Palagini
ItalyClinical experience managing insomnia disorder in patients with neurological comorbidities
Claudio Liguori
ItalySupported by Idorsia Pharmaceuticals Ltd.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 27 Product(s) 7 new product(s) added recently
Open-access sessions from World Sleep 2025 in Singapore. Log into your free World Sleep Society account to view!
After registering for the bundle, navigate to the Content tab and activate sessions of interest to add them to your dashboard.
This free bundle gives you access to the following sessions from World Sleep 2025 in Singapore:
Keynotes
- K-01: Thomas Penzel: Innovations in sleep technology: Advancing diagnosis and treatment of sleep disorders
- K-08: Célyne Bastien: Sleep misperception: A waking perspective
- K-12: Joshua J. Gooley: The hard facts supporting later learning start times
Symposia
- S-04: WSS Task Force recommendations for use of consumer health trackers for sleep tracking
- S-07: Hypersomnolence in focus: Orexin as the key to treating comorbidities and secondary diseases?
- S-12: Narcolepsy: Examining the science, impact, and current unmet needs
- S-13: World Health Organization report on road safety: Pathway to global professional driver work hours regulations
- S-18: iRBD biomarkers through the lens of young scientists: What do we have and what do we need?
- S-25: Open data and open science in sleep medicine and sleep research
- S-40: Best of SLEEP MEDICINE – Journal Highlights 2025
- S-69: Discussion group: Global perspectives on sleep health advocacy: Insights and experiences across five continents
- S-85: Consumer sleep technology: Usefulness and reliability for patients and practitioners
- S-120: Sleep and long COVID: From epidemiology to future prevention on behalf of Second International COVID-19 Sleep Study (ICOSS-II) group
Oral Abstract Sessions
- O-02: Orexin-based therapies and pharmacological advances in narcolepsy
- O-04: Basic Science: Sleep deprivation and sleep disorder
- O-09: Targeting the orexin pathway: Emerging pharmacotherapies for narcolepsy type 1
- O-10: Novel approaches to treating insomnia
- O-13: New sensing or signal analysis methods in sleep
- O-19: New Investigator Award
- O-30: Sleep and public health: Stress, climate, and community
Courses
Industry Sessions
- Bayer: Sleep disturbance across menopause - innovations in measurement and treatment
- Narcolepsy Group Workshop with Takeda
- Nox Medical: Precision Breathing: Advancing Sleep Apnea Phenotyping Through Accurate Flow Measurement
- ProSomnus: Beyond Mandibular Advancement: Science, Innovation and Outcomes
- Resmed: OSA Underdiagnosis- A world of difference, a common challenge
- Idorsia: Managing insomnia disorder in patients with neurological and psychiatric comorbidities
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register
-
Contains 1 Component(s)
Industry Session presented at World Sleep 2025 in Singapore.
Industry Session presented at World Sleep 2025 in Singapore.
-
Register
- Non-member - Free!
- Regular Member - Free!
- Student Member - Free!
- Technician Member - Free!
- More Information
-
Register